Embecta Corp. logo

Embecta Corp.

NASDAQ:EMBC

Overview | Financials
Company Name Embecta Corp.
Symbol EMBC
Currency USD
Price 14.45
Market Cap 833,334,506
Dividend Yield 4.11%
52-week-range 9.925 - 28.99
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Devdatt Kurdikar
Website https://www.embecta.com

An error occurred while fetching data.

About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its

Related Stocks

Vaxcyte, Inc. logo

Vaxcyte, Inc.

PCVX

74.57 USD

Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc.

SUPN

29.1 USD

Dynavax Technologies Corporation logo

Dynavax Technologies Corporation

DVAX

11.11 USD

Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

XENE

39.8 USD

Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

TVTX

6.06 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

164.1 USD

Financials

Numbers are in millions USD

Numbers are in millions USD